\-\ Texto\\:\\ \ \(0\)\
\-\ diffuse\\ expiratory\\ wheezing\ \(0\)\
\-\ \\â\\€\\¢\\ bronchodilators\ \(1\)\
\-\ \\â\\€\\¢\\ steroids\ \(1\)\
\-\ hyperinflated\\ lungs\\ with\\ flattening\\ of\\ hemidiaphragms\\ and\\ increased\\ ap\\ diameter\ \(0\)\
\-\ asthma\\ with\\ air\\ trapping\ \(0\)\
\-\ \\â\\€\\¢\\ reactive\\ airway\\ disease\\ \\(asthma\\)\ \(0\)\
\-\ \\â\\€\\¢\\ viral\\ illness\\ with\\ diffuse\\ air\\ trapping\ \(0\)\
\-\ wheezing\\,\\ no\\ fever\ \(0\)\
\-\ \\â\\€\\¢\\ reactive\\ airway\\ disease\\ and\\ viral\\ illness\\ can\\ have\\ similar\\ features\\ to\\ include\\ bronchial\\ wall\\ thickening\\ \\(cuffing\\ and\\ tram\\-tracks\\)\\,\\ hyperinflation\\ from\\ air\\ trapping\\ \\(partial\\ bronchial\\ obstruction\\)\\,\\ and\\ atelectasis\\ \\(areas\\ of\\ complete\\ bronchial\\ obstruction\\;\\ ie\\:\\ mucous\\ plugging\\)\ \(0\)\
\-\ \\â\\€\\¢\\ airblock\\ phenomena\\ are\\ more\\ likely\\ in\\ asthmatic\\ patients\\,\\ to\\ include\\ pneumomediastinum\\ and\\ pneumothorax\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ trapping\\:\\ 0\\.3567445567201424\ \(0\)\
\-\ bronchial\\:\\ 0\\.31959642996020954\ \(0\)\
\-\ wheezing\\:\\ 0\\.21656050375320354\ \(0\)\
\-\ illness\\:\\ 0\\.21048901785891092\ \(0\)\
\-\ airway\\:\\ 0\\.20987249048691706\ \(0\)\
\-\ asthma\\:\\ 0\\.2086696773149827\ \(0\)\
\-\ air\\:\\ 0\\.20530290757826192\ \(0\)\
\-\ viral\\:\\ 0\\.19301568886008688\ \(0\)\
\-\ reactive\\:\\ 0\\.17958607208403995\ \(0\)\
\-\ airblock\\:\\ 0\\.16731848245615005\ \(0\)\
\-\ bronchodilators\\:\\ 0\\.15460529148577845\ \(0\)\
\-\ asthmatic\\:\\ 0\\.15051255813674752\ \(0\)\
\-\ obstruction\\:\\ 0\\.14656806668124292\ \(0\)\
\-\ hyperinflated\\:\\ 0\\.13973181152143008\ \(0\)\
\-\ cuffing\\:\\ 0\\.13973181152143008\ \(0\)\
\-\ hemidiaphragms\\:\\ 0\\.13779936716637592\ \(0\)\
\-\ phenomena\\:\\ 0\\.1329872766154459\ \(0\)\
\-\ diffuse\\:\\ 0\\.13122590938635453\ \(0\)\
\-\ expiratory\\:\\ 0\\.1280669777414084\ \(0\)\
\-\ plugging\\:\\ 0\\.1280669777414084\ \(0\)\
\-\ include\\:\\ 0\\.12450209083158967\ \(0\)\
\-\ hyperinflation\\:\\ 0\\.12419130322824487\ \(0\)\
\-\ ie\\:\\ 0\\.1195818805688843\ \(0\)\
\-\ pneumomediastinum\\:\\ 0\\.11482211889101653\ \(0\)\
\-\ and\\:\\ 0\\.10809759019422213\ \(0\)\
\-\ mucous\\:\\ 0\\.10791704678886262\ \(0\)\
\-\ flattening\\:\\ 0\\.10318813668692657\ \(0\)\
\-\ atelectasis\\:\\ 0\\.0931638377969002\ \(0\)\
\-\ steroids\\:\\ 0\\.09191988608859988\ \(0\)\
\-\ pneumothorax\\:\\ 0\\.09118319037187549\ \(0\)\
\-\ disease\\:\\ 0\\.08783588985077335\ \(0\)\
\-\ features\\:\\ 0\\.08418490770494555\ \(0\)\
\-\ diameter\\:\\ 0\\.08408656292473071\ \(0\)\
\-\ partial\\:\\ 0\\.08061224485485495\ \(0\)\
\-\ similar\\:\\ 0\\.0797405739870484\ \(0\)\
\-\ lungs\\:\\ 0\\.07721421385992201\ \(0\)\
\-\ ap\\:\\ 0\\.07511396176919734\ \(0\)\
\-\ complete\\:\\ 0\\.07333853934675848\ \(0\)\
\-\ thickening\\:\\ 0\\.07117825035278169\ \(0\)\
\-\ areas\\:\\ 0\\.0710332594193297\ \(0\)\
\-\ fever\\:\\ 0\\.07093723167344579\ \(0\)\
\-\ wall\\:\\ 0\\.06364472250712605\ \(0\)\
\-\ likely\\:\\ 0\\.06252143740225966\ \(0\)\
\-\ with\\:\\ 0\\.061460770429515595\ \(0\)\
\-\ patients\\:\\ 0\\.058857400707518416\ \(0\)\
\-\ more\\:\\ 0\\.05745042890813351\ \(0\)\
\-\ increased\\:\\ 0\\.056576336758588634\ \(0\)\
\-\ can\\:\\ 0\\.05490399391339943\ \(0\)\
\-\ to\\:\\ 0\\.05231219230959639\ \(0\)\
\-\ have\\:\\ 0\\.052266029594044666\ \(0\)\
\-\ from\\:\\ 0\\.041552696445519254\ \(0\)\
\-\ of\\:\\ 0\\.04094937970839233\ \(0\)\
\-\ are\\:\\ 0\\.039700507609193005\ \(0\)\
\-\ no\\:\\ 0\\.03402292671087113\ \(0\)\
\-\ in\\:\\ 0\\.026027355903695416\ \(0\)\
